What is Spect?
Spect operates at the intersection of artificial intelligence and preventative medicine, positioning the human eye as a primary diagnostic window into systemic health. The company provides an end-to-end screening solution that utilizes machine learning to identify eye diseases and predict broader health risks, such as stroke. By enabling medical assistants to generate diagnostic reports in minutes rather than days, Spect addresses critical bottlenecks in clinical efficiency. Their platform is engineered to deliver superior financial outcomes for healthcare providers while simultaneously enhancing the quality of care for patients, effectively serving as a check engine light for the human body.
How much funding has Spect raised?
Spect has raised a total of $3.6M across 2 funding rounds:
Debt
$107K
Angel/Seed
$3.5M
Debt (2021): $107K with participation from PPP
Angel/Seed (2021): $3.5M led by AME Cloud, Morado Ventures, XTX Ventures, and 10x
Key Investors in Spect
Morado Ventures
Morado Ventures is a tech-forward seed fund that invests in exceptional founders developing transformative companies. The firm focuses on early-stage, data-driven companies addressing complex technological challenges across various sectors, including AI, industrial IoT, robotics, and health tech.
AME Cloud
AME Cloud Ventures is a venture capital firm that focuses on early-stage investments in companies building the infrastructure for the next generation of data-driven technology and cloud-based services.
XTX Ventures
XTX Ventures is the venture capital arm of a leading algorithmic trading firm, specializing in investments that leverage deep technical expertise and data-centric approaches to solve complex market and industry problems.
What's next for Spect?
With this major enterprise-level funding, Spect is poised to accelerate the deployment of its diagnostic technology across broader clinical networks. The company's roadmap likely involves scaling its AI-enabled telemedicine infrastructure to support higher volumes of patient screenings and expanding its predictive analytics capabilities to cover a wider array of systemic diseases. As Spect continues to refine its diagnostic algorithms, the focus will remain on integrating seamlessly into existing healthcare workflows, thereby solidifying its role as a foundational element in the future of digital health and preventative diagnostics.
See full Spect company page
